Report Detail
Global and United States 3D Printing Drug Market Report & Forecast 2022-2028
- RnM4441907 |
- 23 May, 2022 |
- Global |
- 75 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
3D printing drugs can realize the advantages of precise control of drug dosage and precise control of release time, which has become one of the focuses of the pharmaceutical industry. The market potential is huge, so the number of companies entering the industry is increasing.
Market Analysis and Insights: Global and United States 3D Printing Drug Market
This report focuses on global and United States 3D Printing Drug market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global 3D Printing Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, ZipDose accounting for % of the 3D Printing Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Oral Solid Dosage Form was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the 3D Printing Drug market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global 3D Printing Drug Scope and Market Size
3D Printing Drug market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global 3D Printing Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the 3D Printing Drug market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the 3D Printing Drug market is segmented into
ZipDose
MED
FDM
SSE
Other
Segment by Application, the 3D Printing Drug market is segmented into
Oral Solid Dosage Form
Non-Oral Solid Dosage Form
Other
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and 3D Printing Drug Market Share Analysis
3D Printing Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in 3D Printing Drug business, the date to enter into the 3D Printing Drug market, 3D Printing Drug product introduction, recent developments, etc.
The major vendors covered:
Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Table of Contents
1 Study Coverage
- 1.1 3D Printing Drug Product Introduction
- 1.2 Global 3D Printing Drug Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global 3D Printing Drug Sales in US$ Million for the Year 2017-2028
- 1.2.2 Global 3D Printing Drug Sales in Volume for the Year 2017-2028
- 1.3 United States 3D Printing Drug Outlook 2017 VS 2022 VS 2028
- 1.3.1 United States 3D Printing Drug Sales in US$ Million for the Year 2017-2028
- 1.3.2 United States 3D Printing Drug Sales in Volume for the Year 2017-2028
- 1.4 3D Printing Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4.1 The Market Share of United States 3D Printing Drug in Global, 2017 VS 2022 VS 2028
- 1.4.2 The Growth Rate of 3D Printing Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.5 3D Printing Drug Market Dynamics
- 1.5.1 3D Printing Drug Industry Trends
- 1.5.2 3D Printing Drug Market Drivers
- 1.5.3 3D Printing Drug Market Challenges
- 1.5.4 3D Printing Drug Market Restraints
- 1.6 Study Objectives
- 1.7 Years Considered
2 Market by Type
- 2.1 3D Printing Drug Market Segment by Type
- 2.1.1 ZipDose
- 2.1.2 MED
- 2.1.3 FDM
- 2.1.4 SSE
- 2.1.5 Other
- 2.2 Global 3D Printing Drug Market Size by Type
- 2.2.1 Global 3D Printing Drug Sales in Value, by Type (2017, 2022 & 2028)
- 2.2.2 Global 3D Printing Drug Sales in Volume, by Type (2017, 2022 & 2028)
- 2.2.3 Global 3D Printing Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
- 2.3 United States 3D Printing Drug Market Size by Type
- 2.3.1 United States 3D Printing Drug Sales in Value, by Type (2017, 2022 & 2028)
- 2.3.2 United States 3D Printing Drug Sales in Volume, by Type (2017, 2022 & 2028)
- 2.3.3 United States 3D Printing Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
- 3.1 3D Printing Drug Market Segment by Application
- 3.1.1 Oral Solid Dosage Form
- 3.1.2 Non-Oral Solid Dosage Form
- 3.1.3 Other
- 3.2 Global 3D Printing Drug Market Size by Application
- 3.2.1 Global 3D Printing Drug Sales in Value, by Application (2017, 2022 & 2028)
- 3.2.2 Global 3D Printing Drug Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 Global 3D Printing Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
- 3.3 United States 3D Printing Drug Market Size by Application
- 3.3.1 United States 3D Printing Drug Sales in Value, by Application (2017, 2022 & 2028)
- 3.3.2 United States 3D Printing Drug Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 United States 3D Printing Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global 3D Printing Drug Competitor Landscape by Company
- 4.1 Global 3D Printing Drug Market Size by Company
- 4.1.1 Top Global 3D Printing Drug Manufacturers Ranked by Revenue (2021)
- 4.1.2 Global 3D Printing Drug Revenue by Manufacturer (2017-2022)
- 4.1.3 Global 3D Printing Drug Sales by Manufacturer (2017-2022)
- 4.1.4 Global 3D Printing Drug Price by Manufacturer (2017-2022)
- 4.2 Global 3D Printing Drug Concentration Ratio (CR)
- 4.2.1 3D Printing Drug Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of 3D Printing Drug in 2021
- 4.2.3 Global 3D Printing Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global 3D Printing Drug Manufacturing Base Distribution, Product Type
- 4.3.1 Global 3D Printing Drug Manufacturers, Headquarters and Distribution of Producing Region
- 4.3.2 Manufacturers 3D Printing Drug Product Type
- 4.3.3 Date of International Manufacturers Enter into 3D Printing Drug Market
- 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
- 4.5 United States 3D Printing Drug Market Size by Company
- 4.5.1 Top 3D Printing Drug Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States 3D Printing Drug Revenue by Players (2020, 2021 & 2022)
- 4.5.3 United States 3D Printing Drug Sales by Players (2020, 2021 & 2022)
5 Global 3D Printing Drug Market Size by Region
- 5.1 Global 3D Printing Drug Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global 3D Printing Drug Market Size in Volume by Region (2017-2028)
- 5.2.1 Global 3D Printing Drug Sales in Volume by Region: 2017-2022
- 5.2.2 Global 3D Printing Drug Sales in Volume Forecast by Region (2023-2028)
- 5.3 Global 3D Printing Drug Market Size in Value by Region (2017-2028)
- 5.3.1 Global 3D Printing Drug Sales in Value by Region: 2017-2022
- 5.3.2 Global 3D Printing Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America 3D Printing Drug Market Size YoY Growth 2017-2028
- 6.1.2 North America 3D Printing Drug Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific 3D Printing Drug Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific 3D Printing Drug Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe 3D Printing Drug Market Size YoY Growth 2017-2028
- 6.3.2 Europe 3D Printing Drug Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America 3D Printing Drug Market Size YoY Growth 2017-2028
- 6.4.2 Latin America 3D Printing Drug Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.4.6 Colombia
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa 3D Printing Drug Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa 3D Printing Drug Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Aprecia Pharmaceuticals
- 7.1.1 Aprecia Pharmaceuticals Corporation Information
- 7.1.2 Aprecia Pharmaceuticals Description and Business Overview
- 7.1.3 Aprecia Pharmaceuticals 3D Printing Drug Sales, Revenue and Gross Margin (2017-2022)
- 7.1.4 Aprecia Pharmaceuticals 3D Printing Drug Products Offered
- 7.1.5 Aprecia Pharmaceuticals Recent Development
- 7.2 Triastek
- 7.2.1 Triastek Corporation Information
- 7.2.2 Triastek Description and Business Overview
- 7.2.3 Triastek 3D Printing Drug Sales, Revenue and Gross Margin (2017-2022)
- 7.2.4 Triastek 3D Printing Drug Products Offered
- 7.2.5 Triastek Recent Development
- 7.3 FabRx
- 7.3.1 FabRx Corporation Information
- 7.3.2 FabRx Description and Business Overview
- 7.3.3 FabRx 3D Printing Drug Sales, Revenue and Gross Margin (2017-2022)
- 7.3.4 FabRx 3D Printing Drug Products Offered
- 7.3.5 FabRx Recent Development
- 7.4 Multiply Labs
- 7.4.1 Multiply Labs Corporation Information
- 7.4.2 Multiply Labs Description and Business Overview
- 7.4.3 Multiply Labs 3D Printing Drug Sales, Revenue and Gross Margin (2017-2022)
- 7.4.4 Multiply Labs 3D Printing Drug Products Offered
- 7.4.5 Multiply Labs Recent Development
8 Industry Chain and Sales Channels Analysis
- 8.1 3D Printing Drug Industry Chain Analysis
- 8.2 3D Printing Drug Key Raw Materials
- 8.2.1 Key Raw Materials
- 8.2.2 3D Printing Drug Distributors
- 8.3 3D Printing Drug Production Mode & Process
- 8.4 3D Printing Drug Sales and Marketing
- 8.4.1 3D Printing Drug Sales Channels
- 8.4.2 3D Printing Drug Distributors
- 8.5 3D Printing Drug Customers
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.2 Data Source
- 10.2 Author Details
Summary:
Get latest Market Research Reports on 3D Printing Drug. Industry analysis & Market Report on 3D Printing Drug is a syndicated market report, published as Global and United States 3D Printing Drug Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of 3D Printing Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
